Illumina Ventures

Arnaud Autret, Illumina Ventures Head of European Operations, is at the 3rd International Spatial Biology Congress in The Netherlands through tomorrow, July 12. This event, organized by Global Engage, is exploring the latest advancements in spatial omics, bioinformatics, and data analysis, as well as the application of spatial biology to disease and drug development. Please reach out to Arnaud for connection opportunities. https://lnkd.in/gzTZmh_f 

Launched in 2018, Illumina Ventures portfolio company Fluent BioSciences Inc., is bringing the power of high-quality single-cell biology to every laboratory by providing scalable, cost-effective, and easy to implement scRNA-seq solutions. The company’s technology, PIPseq, uses pre-templated instant partitions (PIPs), which segregate complex cell samples into uniform reaction partitions that can be easily sequenced – in large or small samples – on high-throughput platforms.     “Fluent’s technology eliminates the need for complex, expensive instrumentation and microfluidic consumables. PIPseq is a simple, scalable workflow that can enable single cell sequencing in every lab for many applications while reducing costs and increasing accessibility,” said Wouter Meuleman, Partner at Illumina Ventures.    Read more about the company, recently acquired by Illumina, here: https://lnkd.in/gCQs_mC3     #partnernews #biotech #singlecell  

Congratulations to Illumina Ventures Portfolio Company Fluent BioSciences Inc. on their acquisition by Illumina. Illumina plans to build on Fluent's technology to develop full end-to-end solutions for single-cell analysis. Read more in Illumina’s press release: https://lnkd.in/gZjfVQBS #partnernews #biotech #singlecell

Illumina Ventures Partner Mara Aspinall joined Theral Timpson on the Mendelspod podcast🎙️to discuss the diagnostic industry in 2024. In this insightful conversation, she discusses the post pandemic trends including advancements in Genomics 3.0. Listen to the full podcast here: https://lnkd.in/gE9ZWsfg 

NanoCellect Biomedical, Inc. has announced the launch of VERLO™ Image-Guided Cell Sorter, a cell sorter poised to redefine the landscape of single-cell visualization and gentle flow cytometry analysis and cell sorting. "The addition of VERLO to our portfolio of high viability cell analysis and sorting platforms will take phenotyping and cell capture to a new level, offering a vantage point into cellular biology that normalizes the defining power of morphology with the molecular resolution of fluorescence." Chris Neary, NanoCellect CEO Read more: https://lnkd.in/gP3eTpaA #partnernews #cellsorting #flowcytometry

Thanks to Illumina Ventures for inviting us to present our #singlecell platform and the promise it holds for faster, more efficient drug development.

Actym Therapeutics, Inc. has announced the appointment of Mary J. Janatpour, PhD, as Chief Scientific Officer and Shouryadeep Srivastava, MD, PhD, as Senior Vice President of Clinical Development. “We are fortunate to attract exceptional individuals with the depth of experience and skills that Mary and Deep bring to the company. Their appointments complete the near-term expansion of our senior team, equipping us with the leadership necessary to drive our product development and achieve our business objectives.” Tom Smart, CEO of Actym. Read more in the full press release: https://lnkd.in/d7GJhPc6 #PartnerNews #leadership #biotech #oncology #tumors

RedShiftBio has released a new study that focuses on the application of Microfluidic Modulation Spectroscopy (#MMS) to identify and analyze the signature absorption peaks of RNA bases—adenine (A), guanine (G), cytosine (C), and uracil (U). The study builds the foundation of the spectral characteristics of each RNA base and explores the implications of spectral variations for understanding the structural and functional aspects of RNAs. View the full app note here: https://lnkd.in/ecCExbtm #PartnerNews #biotech

Last week, our Chief Genomics Officer, Dr. Avni Santani, had the privilege of presenting at the Illumina Ventures 2024 Annual Meeting on the topic, "Healthcare Redefined: Innovative Delivery Models for Home and Beyond." In her session, Dr. Santani delved into how LetsGetChecked’s innovative delivery models are transforming healthcare, bringing chronic disease testing, genomic solutions, and care for millions of lives. She highlighted the critical role of home-based healthcare in improving patient outcomes, increasing accessibility, and driving personalized care. Thank you Illumina Ventures for the opportunity to share our vision and collaborate with industry leaders dedicated to reshaping the future of healthcare.

“Informed by our deep understanding of patient needs and iterative feedback, we developed LetsGetChecked ImPress to specifically address the challenges patients face with blood draws, making the process as painless and efficient as possible.” said CEO Peter Foley Congratulations to LetsGetChecked for being awarded a Red Dot: Product Design 2024 for its upper-arm blood collection device, “LetsGetChecked ImPress”. Learn more: https://lnkd.in/gjMiKfyR #partnernews #diagnostics #healthcare